0001477932-22-002174.txt : 20220408
0001477932-22-002174.hdr.sgml : 20220408
20220408160110
ACCESSION NUMBER: 0001477932-22-002174
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220407
FILED AS OF DATE: 20220408
DATE AS OF CHANGE: 20220408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kway Jasmine
CENTRAL INDEX KEY: 0001808135
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36833
FILM NUMBER: 22816926
MAIL ADDRESS:
STREET 1: 13215 BEE CAVE PARKWAY,
STREET 2: SUITE 125, GALLERIA OAKS B
CITY: AUSTIN
STATE: TX
ZIP: 78738
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VOLITIONRX LTD
CENTRAL INDEX KEY: 0000093314
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 911949078
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13215 BEE CAVE PARKWAY,
STREET 2: SUITE 125, GALLERIA OAKS B
CITY: AUSTIN
STATE: TX
ZIP: 78738
BUSINESS PHONE: 1 (646) 650-1351
MAIL ADDRESS:
STREET 1: 13215 BEE CAVE PARKWAY,
STREET 2: SUITE 125, GALLERIA OAKS B
CITY: AUSTIN
STATE: TX
ZIP: 78738
FORMER COMPANY:
FORMER CONFORMED NAME: STANDARD CAPITAL CORP
DATE OF NAME CHANGE: 19990812
4
1
form4.xml
FORM 4
X0306
4
2022-04-07-05:00
false
0000093314
VOLITIONRX LTD
VNRX
0001808135
Kway Jasmine
13215 BEE CAVE PARKWAY,
SUITE 125, GALLERIA OAKS B
AUSTIN
TX
78738
false
true
false
false
CEO - Singapore Volition
Common Stock
2022-04-07-05:00
4
A
false
9604
0
A
9604
D
Common Stock
5400
I
By Spouse
Stock Option (Right to Buy)
3.40
2022-04-07-05:00
4
A
false
17698
0
A
2031-08-03-05:00
Common Stock
17698
17698
D
On August 3, 2021, the reporting person was awarded 27,440 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 9,604 restricted stock units vesting. The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two equal installments of 4,802 units on each of August 3, 2022 and August 3, 2023, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
On August 3, 2021, the reporting person was granted an option to purchase 50,567 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 17,698 shares vesting. The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 8,849 shares on each of August 3, 2022 and August 3, 2023, respectively.
/s/ Jasmine Kway
2022-04-08-05:00